F
Futtura Oncologia | Porto Alegre, Brazil
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BBO-10203
Exemestane
Tamoxifen
Letrozole
Anastrozole
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 2 total trials
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive,...
Enrolling
Breast Cancer
Drug: Elacestrant
Drug: Tamoxifen
First in human study to evaluate the safety, tolerability, and pharmacokinetics (PK) of BBO-10203, a PI3Kα:RAS breaker, alone and in combination with...
Enrolling
Metastatic Colorectal Cancer
Solid Tumor, Adult
Drug: Ribociclib
Drug: BBO-10203
Trial sponsors
T
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems